The US Patent Office has awarded Sabinsa Corporation a patent (US 8193156) for the preparatory route for dipeptides incorporating selenoamino acids.

The patent is titled "Dipeptides incorporating selenoamino acids with enhanced bioavailability--synthesis, pharmaceutical and cosmeceutical applications thereof," is specific to the preparatory route for L-Selenomethionine peptide having not only excellent vascular endothelial growth factor (VEGF) and anti-5-alpha reductase activity, which are important properties for maintaining perfect homeostasis for "hair care", but also increased water solubility and bioavailability, enhancing their benefits in hair care industry.

Dr. Anurag Pande, Sabinsa's Vice President, Scientific Affairs, said "this discovery by the Sabinsa research team creates a lot of opportunity given the product's capabilities to prevent and reduce hair loss, maintaining perfect homeostasis for hair care."

This patent represents the 72^nd in Sabinsa Corporation’s global patent portfolio.